Rescue of neurological deficits in a mouse model for Angelman syndrome by reduction of αCaMKII inhibitory phosphorylation
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Angelman syndrome (AS) is a severe neurological disorder characterized by mental retardation, motor dysfunction and epilepsy. We show that the molecular and cellular deficits of an AS mouse model can be rescued by introducing an additional mutation at the inhibitory phosphorylation site of alphaCaMKII. Moreover, these double mutants no longer show the behavioral deficits seen in AS mice, suggesting that these deficits are the direct result of increased inhibitory phosphorylation of alphaCaMKII.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Several mouse models of ASD, including those of Rett syndrome96,97, Angelman syndrome98, tuberous sclerosis complex71, and Fragile X23 syndrome, and mouse models of rare mutations in SHANK proteins49, have provided convincing evidence that ASD phenotypes can be improved by genetic or pharmacological interventions”
From Activity-dependent neuronal signalling and autism spectrum disorder (2013) · cites this paper as [98]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
UBE3A/E6-AP mutations cause Angelman syndrome
Kishino, T., Lalande, M., & Wagstaff, J. (1997) · Nature Genetics · doi:10.1038/ng0197-70 · Cited by 1,298
De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome
Matsuura, T., Sutcliffe, J. S., Fang, P., Galjaard, R.-J., Jiang, Y.-H., Benton, C. S., Rommens, J. M., & Beaudet, A. L. (1997) · Nature Genetics · doi:10.1038/ng0197-74 · Cited by 856
Self-citationJiang, Y.-H., Armstrong, D., Albrecht, U., Atkins, C. M., Noebels, J. L., Eichele, G., Sweatt, J. D., & Beaudet, A. L. (1998) · Neuron · doi:10.1016/s0896-6273(00)80596-6 · Cited by 852
Self-citationAlbrecht, U., Sutcliffe, J. S., Cattanach, B. M., Beechey, C. V., Armstrong, D., Eichele, G., & Beaudet, A. L. (1997) · Nature Genetics · doi:10.1038/ng0997-75 · Cited by 583
Knoll, J. H. M., Nicholls, R. D., Magenis, R. E., Graham, J. M., Lalande, M., Latt, S. A., Opitz, J. M., & Reynolds, J. F. (1989) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320320235 · Cited by 576
Inhibitory Autophosphorylation of CaMKII Controls PSD Association, Plasticity, and Learning
Elgersma, Y., Fedorov, N. B., Ikonen, S., Choi, E. S., Elgersma, M., Carvalho, O. M., Giese, K. P., & Silva, A. J. (2002) · Neuron · doi:10.1016/s0896-6273(02)01007-3 · Cited by 290
Self-citationWeeber, E. J., Jiang, Y.-H., Elgersma, Y., Varga, A. W., Carrasquillo, Y., Brown, S. E., Christian, J. M., Mirnikjoo, B., Silva, A., Beaudet, A. L., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02634.2003 · Cited by 264
Self-citationClayton‐Smith, J. (1993) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320460105 · Cited by 247
αCaMKII Is Essential for Cerebellar LTD and Motor Learning
Hansel, C., de Jeu, M., Belmeguenai, A., Houtman, S. H., Buitendijk, G. H. S., Andreev, D., De Zeeuw, C. I., & Elgersma, Y. (2006) · Neuron · doi:10.1016/j.neuron.2006.08.013 · Cited by 230
Self-citationElgersma, Y., Sweatt, J. D., & Giese, K. P. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3622-04.2004 · Cited by 148
Self-citation
Cited by
Items 201–277 of 277
Hu, J.-H., Malloy, C., Liu, Y., Park, J. M., Pratt, A. E., Welch, M. A., Murphy, J. G., Abebe, D. T., Karlsson, R., Cameron, H. A., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115583 · Cited by 10
Rayi, P. R., Bagrov, A. Y., & Kaphzan, H. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-00907-1 · Cited by 11
Sun, J., Liu, Y., Hao, X., Baudry, M., & Bi, X. (2022) · Neural Plasticity · doi:10.1155/2022/3923384 · Cited by 11
Sex-specific effects of Cre expression in Syn1Cre mice
Baghdadi, M., Mesaros, A., Purrio, M., & Partridge, L. (2023) · Scientific Reports · doi:10.1038/s41598-023-37029-9 · Cited by 12
Su, W., Liu, Y., Lam, A. J., Hao, X., Baudry, M., & Bi, X. (2023) · Scientific Reports · doi:10.1038/s41598-023-45769-x · Cited by 9
Genomic imprinting and communicative behaviour: Prader-Willi and Angelman syndrome
Smit, H. (2009) · Netherlands journal of psychology · doi:10.1007/bf03080130 · Cited by 10
Schultz, M. N., & Crawley, J. N. (2020) · Learning & Memory · doi:10.1101/lm.051201.119 · Cited by 10
Huie, E. Z., Yang, X., Rioult-Pedotti, M. S., Tran, K., Monsen, E. R., Hansen, K. M., Erickson, M. A., Naik, M. T., Yotova, A. Y., Banks, W. A., et al. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-02020-z · Cited by 8
A patogênese genética e molecular da síndrome de Angelman
Maris, A. F., & Trott, A. (2011) · Jornal Brasileiro de Psiquiatria · doi:10.1590/s0047-20852011000400014 · Cited by 14
Elamin, M., Lemtiri‐Chlieh, F., Robinson, T. M., & Levine, E. S. (2023) · Epilepsia · doi:10.1111/epi.17687 · Cited by 9
Lukesch, H., & Schüller, H. (1989) · University of Regensburg Publication Server (University of Regensburg) · Cited by 15
Mezzena, R., Masciullo, C., Antonini, S., Cremisi, F., Scheffner, M., Cecchini, M. G., & Tonazzini, I. (2020) · Nanotechnology · doi:10.1088/1361-6528/abbb03 · Cited by 9
Gene therapy for Rett syndrome: prospects and challenges
Gadalla, K. K. E., Ross, P., Hector, R., Bahey, N., Bailey, M., & Cobb, S. (2015) · Future Neurology · doi:10.2217/fnl.15.29 · Cited by 5
Genetic Engineering Cures Mice of Neurological Deficits: Prospects for Treating Angelman Syndrome
Elgersma, Y. (2007) · Pharmacogenomics · doi:10.2217/14622416.8.6.539 · Cited by 11
Self-citationRayi, P. R., & Kaphzan, H. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.670998 · Cited by 8
Biagioni, M., Baronchelli, F., & Fossati, M. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106669 · Cited by 7
Neurodevelopmental Underpinnings of Angelman Syndrome
Li, G. (2014) · Journal of Bioanalysis & Biomedicine · doi:10.4172/1948-593x.1000111 · Cited by 6
Characterizing spine issues: If offers novel therapeutics to Angelman syndrome
Yang, X. (2020) · Developmental Neurobiology · doi:10.1002/dneu.22757 · Cited by 7
Degradation of CaMKII is stimulated by its active conformation
Quasney, C., & Griffith, L. C. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110601 · Cited by 7
Negrón-Moreno, P. N., Diep, D. T., Guoynes, C. D., & Sidorov, M. S. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.968159 · Cited by 5
Hyperphagia, Growth, and Puberty in Children with Angelman Syndrome
Heus, K. B., Hagenaar, D. A., Dekker, I., van der Kaay, D. C. M., Kerkhof, G. F., Elgersma, Y., de Wit, M. Y., Mous, S. E., & Moll, H. A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12185981 · Cited by 5
Self-citationOutcome measures in Angelman syndrome
Hagenaar, D. A., Heus, K. B., van Gils, M. M., van den Berg, L., ten Hoopen, L. W., Affourtit, P., Pel, J. J. M., Joosten, K. F. M., Hillegers, M. H. J., Moll, H. A., et al. (2024) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-024-09516-1 · Cited by 8
Ash, R. T., Buffington, S. A., Park, J., Costa‐Mattioli, M., Zoghbi, H. Y., & Smirnakis, S. M. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/100875 · Cited by 6
Carriero, P. L., Zangari, R., Sfreddo, E., Ghirardi, A., Schieppati, A., Barbui, T., & Biroli, F. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13123520 · Cited by 5
Mathews, J. M., Cook, E. K., Margolis, S. S., & Williams, C. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813955-4.00024-6 · Cited by 4
Panov, J., & Kaphzan, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169139 · Cited by 4
Sweatt, J. D. (2007) · Cell · doi:10.1016/j.cell.2007.03.021 · Cited by 4
The molecular basis of cognitive deficits in pervasive developmental disorders: Table 1.
Bhattacharya, A., & Klann, E. (2012) · Learning & Memory · doi:10.1101/lm.025007.111 · Cited by 6
Fitzgerald, P. J. (2024) · Epilepsy Research · doi:10.1016/j.eplepsyres.2024.107286 · Cited by 4
Towards targeted therapy for Angelman syndrome
Ciarlone, S. L., & Weeber, E. J. (2016) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2015.1136557 · Cited by 3
Self-citationSodium-potassium ATPase emerges as a player in hippocampal phenotypes of Angelman syndrome mice
Hallengren, J. J., & Vaden, R. J. (2014) · Journal of Neurophysiology · doi:10.1152/jn.00760.2013 · Cited by 5
Postsynaptic Targeting of Protein Kinases and Phosphatases
Strack, S., & Hell, J. W. (2008) · Springer eBooks · doi:10.1007/978-0-387-77232-5_16 · Cited by 5
CaMKII: Mechanisms of a Prototypical Memory Model
Colbran, R. J. (2008) · Elsevier eBooks · doi:10.1016/b978-012370509-9.00023-1 · Cited by 3
Stevens-Bullmore, H., Kulasiri, D., & Samarasinghe, S. (2022) · Molecules · doi:10.3390/molecules27185974 · Cited by 2
Dysfunction of the Methyl-CpG-Binding Protein MeCP2 in Rett Syndrome
Calfa, G. D., Percy, A. K., & Pozzo‐Miller, L. D. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3345-3_3 · Cited by 2
Prader–Willi and Angelman syndromes
Smith, E. Y., & Resnick, J. L. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107360556.019 · Cited by 2
Genetic Mechanisms of Memory Disorders (Excluding Alzheimer's Disease)
Kaas, G. A., Hawkins, K. E., & Sweatt, J. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.21125-5 · Cited by 3
Genetic and Pharmacological Reversibility of Phenotypes in Mouse Models of Autism Spectrum Disorder.
Schroeder, J., Deliu, E., Novarino, G., & Schmeisser, M. (2017) · Advances in Anatomy, Embryology and Cell Biology · doi:10.1007/978-3-319-52498-6_10 · Cited by 2
Critical periods and neurodevelopmental brain disorders
Meredith, R. M. (2016) · Wiley eBooks · doi:10.1002/9781118931684.ch4 · Cited by 3
Mayor, U., Alduntzin, U., Lectez, B. L. P., Presa, N., Osinalde, N., Fernandez, M., Elu, N., Ramírez, J., Garcia-Barcena, C., Aloria, K., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2665803/v1 · Cited by 2
Emerging Research towards the Understanding and Treatment of Autism
Wang, P. P., Hammond, R., Postma, F. R., & Healy, A. M. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849734943-00384 · Cited by 1
E3 ubiquitin ligases and cerebral cortex development in health and disease
Lambert, N., Moïse, M., & Nguyen, L. (2022) · Developmental Neurobiology · doi:10.1002/dneu.22877 · Cited by 1
CaMKIIα hub ligands are unable to reverse known phenotypes in Angelman syndrome mice
Gauger, S. J., Lie, M. E. K., Wallaard, I., Tian, Y., Marek, A., Frølund, B., van Woerden, G. M., Elgersma, Y., Kornum, B. R., & Wellendorph, P. (2024) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.14112 · Cited by 1
Self-citationMontgomery, D. P., Shide, J. J., Didouchevski, A. M., Dickinson, A. H., & Sidorov, M. S. (2026) · Communications Medicine · doi:10.1038/s43856-026-01741-0 · Cited by 3
Williams, C. A., & Mueller, J. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-410529-4.00020-6 · Cited by 1
Bolivar, V. J. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107360556.012 · Cited by 1
Insights into synaptic function from mouse models of human cognitive disorders
Banko, J. L., Trotter, J. H., & Weeber, E. J. (2010) · Future Neurology · doi:10.2217/fnl.10.80 · Cited by 1
Self-citationInduced pluripotent stem cells for modeling Angelman syndrome
Maranga, C., Vieira, A. A., Bekman, E., & da Rocha, S. T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85764-2.00015-6 · Cited by 1
Ubiquitin and Protein Degradation in Synapse Function
Helton, T. D., & Ehlers, M. (2008) · Springer eBooks · doi:10.1007/978-0-387-77232-5_19 · Cited by 1
Genomic Imprinting Effects on Brain and Behavior: Future Directions
Isles, A. R., & Wilkinson, L. S. (2011) · Springer eBooks · doi:10.1007/978-3-642-17426-1_9 · Cited by 1
Yang, X., Mayoral, S., Jiang, Y.-H., Marshall, J., & Huang, Y. A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.21.726878 · Cited by 3
Self-citationFilonova, I. (2014) · Digital Commons - University of South Florida (University of South Florida)
Parental and carer responses to Angelman syndrome and Prader-Willi syndrome.
Thomson, A. (2011) · Research Online (Edith Cowan University)
Grieco, J. C. (2015) · Digital Commons - University of South Florida (University of South Florida) · Cited by 1
Low, D. (2012) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/48088
The Lessons from Angelman Syndrome for Research and Management
Pelc, K., Chéron, G., & Dan, B. (2011) · InTech eBooks · doi:10.5772/21808 · Cited by 1
Social dysfunction and mental retardation
Pietropaolo, S., Sluyter, F., & Crusio, W. E. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107360556.010 · Cited by 1
LeBoeuf, B. (2009) · OakTrust (Texas A&M University Libraries)
Molecular mechanisms of synapse pathology in ATR-X syndrome
Shioda, N., & Fukunaga, K. (2015) · Folia Pharmacologica Japonica · doi:10.1254/fpj.145.174
CaMKII Autophosphorylation-Dependent Learning and Memory
Vigil, F. A., & Giese, K.-P. (2015) · Springer eBooks · doi:10.1007/978-3-319-24364-1_4
Bruinsma, C. F., Schonewille, M., Gao, Z., Judson, M. C., Philpot, B. D., Hoebeek, F. E., van Woerden, G. M., Zeeuw, C. I. D., & Elgersma, Y. (2015)
Self-citationImprinting in the CNS and Neurodevelopmental Disorders
Powell, W. T., & LaSalle, J. M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-391494-1.00010-0
Mouse Behavioral Models for Autism Spectrum Disorders
Wetsel, W. C., Moy, S. S., & Jiang, Y.-H. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-391924-3.00026-0
Self-citationInherited Disorders of Human Memory—Mental Retardation Syndromes
Sweatt, J. D. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374951-2.00011-1
Dendritic Protein Phosphatase Complexes
Baucum, A. J., & Colbran, R. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00167-4
The Angelman Approach : hacking DNA to treat a rare disease
Levy, B. A. (2017)
Синдром Ангельмана. Часть 1 (этиология и патогенез)
Абатуров, А. Е., Petrenko, L. L., & Krivusha, Y. L. (2020) · CHILD`S HEALTH · doi:10.22141/2224-0551.5.65.2015.74907
Sensory experience-dependent synaptic modifications in the visual cortex
Yashiro, K. (2008) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/02ds-km68
Ghrelin-axis function in the context of Adult Hippocampal Neurogenesis
Hornsby, A. K. E. (2018) · Cronfa (Swansea University) · doi:10.23889/suthesis.50587
The role of Ca2+/calmodulin-dependent kinase II in normal and abnormal early postnatal development
Gustin, R. M. (2010)
Self-citationInvestigation of CaMKII activation: a model of self-regulation
Hoffman, L. (2011)
Mathews, J. M., & Jalazo, E. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19041-4.00024-8
Penna, E., Pizzella, A., Abate, N., Conte, N., Cimmino, F., Mollica, M. P., Giaimo, R. D., Baudry, M., Bi, X., & Crispino, M. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115689 · Cited by 1
Duma, G. M., Bagnoli, M., Stefanelli, G., Mazzara, C., Pellegrino, G., Mento, G., Sorrentino, P., Toffoli, L., Cristaldi, F. D. P., Antoniazzi, L., et al. (2026) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2026.100794
Sultana, S., Ray, S., Samaddar, S., & Banerjee, S. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1883287
Impaired Kv4.2-DPP6 complex dynamics in a mouse model of Angelman syndrome
Hu, J.-H., Liu, Y., Malloy, C., & Hoffman, D. A. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1953686
Metadata
- Authors
- van Woerden, G. M., Harris, K. D., Hojjati, M. R., Gustin, R. M., Qiu, S., de Avila Freire, R., Jiang, Y.-H., Elgersma, Y., & Weeber, E. J.
- Affiliations
- Vanderbilt University (US)
- Erasmus MC (NL)
- Baylor College of Medicine (US)
- Corresponding author
- Elgersma, Ype
- Venue
- Nature Neuroscience
- Published
- 2007-01-28
- Volume
- 10
- Issue
- 3
- Pages
- 280-282
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W2149631083
- Cited by
- 281
- References
- 15
- Citations by year
- 2026: 6 · 2025: 3 · 2024: 9 · 2023: 8 · 2022: 9 · 2021: 14 · 2020: 19 · 2019: 14 · 2018: 10 · 2017: 20 · 2016: 11 · 2015: 27 · 2014: 17 · 2013: 19 · 2012: 18
- FWCI
- 9.47
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Angelman syndrome, CaMKIIα, inhibitory phosphorylation, mouse model, neurological deficit, intellectual disability, epilepsy, motor impairment
- MeSH terms
- Animals, Behavior, Animal, Mental Disorders, Conditioning, Classical, Disease Models, Animal, Female, Hippocampus, Male, Mice, Inbred C57BL, Mice, Neurologic Mutants, Motor Activity, Phosphorylation, Phosphotransferases, Reaction Time, Time Factors, Angelman Syndrome, Maze Learning, Excitatory Postsynaptic Potentials, Ubiquitin-Protein Ligases, Freezing Reaction, Cataleptic, Mice, Calcium-Calmodulin-Dependent Protein Kinase Type 2, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.